The chemopreventive efficacy of inhaled oltipraz particulates in the B[a]P-induced A/J mouse lung adenoma model

Carcinogenesis

Volumn 27, Issue 8, 2006, Pages 1721-1727

  Sharma, Sheela ^a   Gao, Pu ^a   Steele, Vernon E ^b  

^a ALION SCIENCE AND TECHNOLOGY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZO[A]PYRENE; OLTIPRAZ;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; CANCER INCIDENCE; CANCER INHIBITION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG EFFICACY; FEEDING; FEMALE; LUNG ADENOMA; LUNG CARCINOGENESIS; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PARTICULATE MATTER; PRIORITY JOURNAL; TOXICITY TESTING; WEIGHT GAIN;

ADENOMA; ANIMALS; ANTICARCINOGENIC AGENTS; BENZO(A)PYRENE; FEMALE; INHALATION; LUNG NEOPLASMS; MICE; MICE, INBRED A; PYRAZINES;

EID: 33747876093     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl052     Document Type: Article

References (43)

1. U.S. National Research Council. (1986) Environmental Tobacco Smoke: Measuring Exposures and Assessing Health Effects. National Academy Press, Washington, D.C. pp. 223-249.
2. Thyssen,J., Althoff J., Kimmerle,G. and Mohr,U. (1981) Inhalation studies with benzo[a]pyrene in Syrian golden hamsters. J. Natl. Cancer Inst., 66, 575-577.
3. Shimkin,M.B. and Stoner,G.D. (1975) Lung tumors in mice: Application to carcinogenesis bioassay. Adv. Cancer Res., 21, 2-58.
4. Stoner,G.D. and Shimkin,M.B. (1982) Strain A mouse lung tumor bioassay. J. Am. Coll. Toxicol., 1, 145-169.
5. Stoner,G.D. (1991) Lung tumors in strain A mice as a bioassay for carcinogenicity of environmental chemicals. Exp. Lung Res., 17, 405-423.
6. Stoner,G.D., You,M., Morgan,M.A. and Superczynski,M.J. (1986) Lung tumor induction in strain A mice with benzotrichloride. Cancer Lett., 33, 167-173.
7. Adkins,B.Jr., Van Stee,E.W., Simmons,J.E. and Eustis,S.L. (1986) Oncogenic response of strain A/J mice to inhaled chemicals. J. Toxicol. Environ. Health, 17, 311-322.
8. Dahl,A.R., Grossi,I.M., Houchens,D.P., Scovell,L.J., Placke,M.E., Imondi,A.R., Stone,G.D., De Luca,L.M., Wang,D. and Mulshine,J.L. (2000) Inhaled isotretinoin (13-cis-retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: A pilot study. Clin. Cancer Res., 6, 3015-3024.
9. Spinella,M.J. and Dmitrovsky,E. (2000) Aerosolized delivery and lung cancer prevention: Pre-clinical models show promise. Clin. Cancer Res., 6, 2963-2964.
10. Mimoto,J., Kiura,K., Matsuo,K., Yoshino,T., Takata,I., Ueoka,H., Kataoka,M. and Harada,M. (2000) (-)-Epigallocatechin gallate can prevent cisplatin-induced lung tumorigensis in A/J mice. Carcinogenesis, 21, 915-919.
11. Chung,F.L. (2001) Chemoprevention of lung cancer by isothiocyanates and their conjugates in A/J mouse. Exp. Res., 27, 319-330.
12. Yang,Y-M., Conaway,C.C., Chiao,J.W., Wang,C-X., Amin,S.J., Whysner,S., Dai,W., Reinhardt,J. and Chung,F-L. (2002) Inhibition of benzo(a)pyrene-induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen-activated protein kinases and p53 activity and induction of apoptosis. Cancer Res., 62, 2-7.
13. Hecht,S.S., Kenney,P.M., Wang,M. and Upadhyaya,P. (2002) Benzyl isothiocyanate: An effective inhibitor of polycyclic aromatic hydrocarbon tumorigenesis in A/J mouse lung. Cancer Lett., 187, 87-94.
14. Wang,Z., Chen,H.T., Roa,W. and Finlay,W. (2003) Farnesol for aerosol inhalation: Nebulization and activity against human lung cancer cells. J. Pharm. Sci., 6, 95-100.
15. Liao,J., Yang,G.Y., Park,E.S., Meng,X., Sun,Y., Jia,D., Seril,D.N. and Yang,C.S. (2004) Inhibition of lung carcinogenesis and effect on angiogenesis and apoptosis in A/J mice by oral administration of green tea. Nutr. Cancer, 48, 44-53.
16. Egner,A.E., Kensler,T.W., Prestera,T., Talalay,P., Libby,A.H., Joyner,H.H. and Curphey,T.J. (1994) Regulation of phase 2 enzyme induction by oltipraz and other dithiolthiones. Carcinogenesis, 15, 177-181.
17. Kensler,T.W. (1997) Chemoprevention by inducers of carcinogen detoxification enzymes. Environ. Health Perspect., 105, 1-10.
18. Benson,A.B. III. (1993) Oltipraz: A laboratory and clinical review. J. Cell Biochem., 17F, 275-291.
19. 1 metabolism in human hepatocytes in primary culture. Cancer Res., 55, 5574-5579.
20. Smith,W.A. and Gupta,R.C. (1996) Use of a microsome-mediated test system to assess efficacy and mechanisms of cancer chemopreventive agents. Carcinogenesis, 17, 1285-1290.
21. Kensler,T.W., Egner,P.A., Dolan,P.M., Groopman,G.D. and Roebuck,B.D. (1987) Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones, Cancer Res., 47, 4271-4277.
22. Sharma,S., Stutzman,J.D., Kelloff,G.J. and Steele,V.E. (1994) Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res., 54, 5848-5855.
23. Rao,C.V., Nayini,J. and Reddy,B.S. (1991) Effect of oltipraz [5-(2-pyrazinyl)-4-methyl-1-2-dithiol-3 thione] on azoxymethane-induced biochemical changes related to early colon carcinogenesis in male F-344 rats. Proc. Soc. Exp. Biol. Med., 197, 77-84.
24. Rao,C.V., Rivenson,A., Katiwalla,M., Kelloff,G.J. and Reddy,B.S. (1993) Chemopreventive effect of olitpraz during different stages of experimental colon carcinogenesis induced by azoxymethane in male F-344 rats. Cancer Res., 53, 2502-2506.
25. Kelloff,G.J., Boone,C.W., Malone,W.F., Steele,V.E. and Doody,L.A. (1992) Development of chemopreventive agents for bladder cancer. J. Cell Biochem. Suppl., 161, 1-12.
26. Wattenberg,L.W. and Bueding,E. (1986) Inhibitory effects of 5-(2-pyrazinyl)-4-methyl-1, 2-dithiol-3-thione (oltipraz) on carcinogenesis induced by benzo[a]pyrene, diethylnitrosamine and uracil mustard. Carcinogenesis, 8, 1379-1381.
27. Morse,M.A., Hongxiang,Z., Kresty,L.A. and Stoner,G.D. (1995) Failure of dietary oltipraz to inhibit benzo[a]pyrene-induced lung tumorigenesis in strain A mice. Cancer Lett., 91, 133-138.
28. Pepin,P., Bouchard,L., Nicole,P. and Castonguay,A. (1992) Effects of sunlindac and oltipraz on the tumorigenicity of 4-(methylnitrosamino)1-(3-pyridyl)-1-butanone in A/J mouse lung. Carcinogenesis, 13, 341-348.
29. Aboul-Atta,A.M., Hassan,Z.A., Awadallah,F.E., el-Ahl,S.S. and Hamdy,B.H. (1990) Oltipraz treatment in experimental schistosomiasis mansoni: VII. Effect of high dose oral therapy on alkaline phosphatase levels in livers of infected mice. J. Egypt. Soc. Parasitol., 20, 221-230.
30. Jacobson,L.P., Zhang,B-C., Zhu,Y-R. et al. (1997) Oltipraz Chemoprevention Trial in Qidong, People's Republic Study Design and Clinical Outcomes. Cancer Epidemiol. Biomarkers Prev., 6, 257-265.
31. Kensler,T.W. and Helzlsouer,K.J. (1995) Oltipraz: Clinical opportunities for cancer chemoprevention. J. Cell Biochem., 22S, 101-107.
32. Kensler,T.W., He,X., Otieno,M. et al. (1998) Oltipraz chemoprevention trial in Qidong, People's Republic of China: Modulation of serum aflatoxin albumin adduct biomarkers. Cancer Epidemiol. Biomarkers Prev., 7, 127-134.
33. Rehm,S., Ward,J.M. and Sass,B. (1994) Tumours of the lungs. In: Turusov, V. and Mohr, U. (eds) Pathology of Tumours in Laboratory Animals, Vol 2, Tumours of the Mouse. IARC Scientific publications, Lyon, France. pp. 325-355.
34. Armitage,P. (1966) The chi-square test for heterogeneity of proportions after adjustment for stratification. J. R. Stat. Soc. Ser B., 28, 150-163.
35. Agresti,A. (1990) Categorical Data Analysis, Chapter IV: Models for Binary Response Variable, Cochran-Armitage Test. John Wiley and Sons, New York, pp. 100-102.
36. Kelloff,G.J., Crowell,J.A., Boone,C.W. et al. (1994) Strategy and planning for chemopreventive drug development: Clinical development plan: Oltipraz. J. Cell Biochem. Suppl., 20, 205-218.
37. Ebert,B., Seidel,A. and Lampen,A. (2005) Induction of phase-1 metabolizing enzymes by oltipraz, flavone and indole-3-carbinol enhance the formation and transport of benzo[a]pyrene sulfate conjugates in intestinal Caco-2 cells. Toxicol. Lett., 158, 140-151.
38. Lam,S., MacAulay,C., Le Riche,J.C., Dyachkova,Y., Coldman,A., Guillaud,M., Hawk,E., Christen,M-O and Gazdar,A.F. (2002) A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasia. J. Natl. Cancer Inst., 94, 1001-1009.
39. Mass,M.J., Jeffers,A.J., Ross,J.A., Nelson,G., Galati,A.J. and Stoner,G.D. (1993) Benzo[a]pyrene in the lungs of strain A/J mice. Mol. Carcinog., 8, 186-192.
40. You,M., Candrian,U., Maronpot,R.R., Stoner,G.D. and Anderson,M.W. (1989) Activation of the K-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse. Proc. Natl. Acad. Sci. USA, 86, 3070-3074.
41. You,M., Reynolds,S.H., Maronpot,R.R., Stoner,G.D. and Anderson,M.W. (1990) Activated oncogenes in rodent and human lung tumors. In: Thomassen,D.G. and Nettesheim,P. (eds) Biology, Toxicology, and Carcinogenesis of Respiratory Epithelium. New York, Hemisphere Publishing Corp. pp. 271-277.
42. Boone,C.W., Kelloff,G.W. and Malone,W.E. (1990) Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: A review. Cancer Res., 50, 2-9.
43. Moon,R.C. and Mehta,R.G. (1989) Chemoprevention of experimental carcinogenesis in animals. Prev. Med., 18, 576-591.